Reduction of Candida species colonization in the oral cavity of children infected with human immunodeficiency virus after dental treatment

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 108, Issue 3, 2009, Pages 383-388

  das Chagas, Madeleine Souza ^a   Portela, Maristela Barbosa ^a   Cerqueira, Daniella Ferraz ^b   de Souza, Ivete Pomarico Ribeiro ^a   Soares, Rosangela Maria ^a   Castro, Gloria Fernanda ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTICARIES AGENT; FLUORIDE VARNISH;

ARTICLE; BACTERIAL COUNT; CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; CD4 LYMPHOCYTE COUNT; CHILD; CLASSIFICATION; COMPARATIVE STUDY; DENTAL CARE; DENTAL CARIES; DENTAL SURGERY; DENTIN; FEMALE; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MOUTH MUCOSA; PRESCHOOL CHILD; TOOTH BRUSHING; TOOTH EXTRACTION; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; CARIOSTATIC AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DENTAL CARE; DENTAL CARIES; DENTAL RESTORATION, PERMANENT; DENTIN; FEMALE; FLUORIDES, TOPICAL; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MOUTH MUCOSA; TOOTH EXTRACTION; TOOTHBRUSHING; VIRAL LOAD;

EID: 69149093309     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.04.038     Document Type: Article

References (42)

1. Bosco V.L., Birman E.G., Cury A.E., and Paula C.R. Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance. Pesq Odontol Bras 17 (2003) 217-222
2. Pongsiriwet S., Iamaroon A., Sriburee P., Pattanaporn K., and Krisanaprakornkit S. Oral colonization of Candida species in perinatally HIV-infected children in Northern Thailand. J Oral Sci 46 (2004) 101-105
3. Chattopadhyay A., Caplan D.J., Slade G.D., Shugars D.C., Tien H.-C., and Patton L.L. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent Oral Epidemiol 33 (2005) 35-44
4. Portela M.B., Souza I.P.R., Costa E.M.M.B., Hagler A.N., Soares R.M.A., and Santos A.L.S. Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil. J Clin Microbiol 42 (2004) 5925-5927
5. Jabra-Hizk M.A., Falker Jr. W.A., Merz W.G., Baqui A.A.M.A., Kelley J.I., and Meiller T.F. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-infected individuals. J Clin Microbiol 38 (2000) 2423-2426
6. Sweet S.P. Selection and pathogenicity of Candida albicans in HIV infection. Oral Dis 3 Suppl. 1 (1997) S88-S95
7. Jacob L.S., Flaitz C.M., Nichols M., and Hicks J.M. Role of dentinal carious lesions in the pathogenesis of oral candidiasis in HIV infection. J Am Dent Assoc 129 (1998) 187-194
8. Blignaut E. Oral candidiasis and oral yeast carriage among institutionalized South African paediatric HIV/AIDS patients. Mycopathologia 163 (2007) 67-73
9. Kerdpon D., Pongsiriwet S., Pangsomboon K., Iamaroon A., Kampoo K., Sretrirutchai S., et al. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 10 (2004) 138-144
10. + lymphocyte count in HIV-positive patients in China. Oral Dis 12 (2006) 41-44
11. Santos L.C., Castro G.F., Souza I.P., and Oliveira R.H.S. Oral manifestations related to immune suppression degree in HIV-positive children. Braz Dent J 12 (2001) 135-138
12. Castro G.F., Souza I.P.R., Lopes S., Stashenko P., and Teles R.P. Salivary IgA to cariogenic bacteria in HIV-positive children and its correlation with caries prevalence and levels of cariogenic microorganisms. Oral Microbiol Immunol 19 (2004) 281-288
13. Frezzini C., Leão J.C., and Porter S. Current trends of HIV disease of the mouth. J Oral Pathol Med 34 (2005) 513-531
14. Madigan A., Murray P.A., Houpt M., Catalanotto F., and Feuerman M. Caries experience and cariogenic markers in HIV-positive children and their siblings. Pediatr Dent 18 (1996) 129-136
15. Hossain H., Ansari F., Schulz-Weidner N., Wetzel W.-E., Chakraborty T., and Domann E. Clonal identity of Candida albicans in the oral cavity and the gastrointestinal tract of pre-school children. Oral Microbiol Immun 18 (2003) 302-308
16. Rego M.A., Koga-Ito C.Y., and Jorge A.O.C. Effects of oral environment stabilization procedures on counts of Candida ssp. in children. Pesqui Odontol Bras 17 (2003) 322-326
17. Sziegoleit F., Sziegoleit A., and Wetzel W.E. Effect of dental treatment and/or local application of amphotericin B to carious teeth on oral colonization by Candida. Med Mycol 37 (1999) 345-350
18. Carvalho F.G., Silva D.S., Hebling J., Spolidoro L.C., and Spolidoro D.M. Presence of mutans streptococci and Candida spp. in dental plaque/dentin of carious teeth and early childhood caries. Arch Oral Biol 51 (2006) 1024-1028
19. Cerqueira D.F., Portela M.B., Pomarico L., Soares R.M.A., Souza I.P.R., and Castro G.F. Dentinal carious lesions: a predisposing factor for the oral prevalence of Candida ssp. in HIV-infected children. ASDC J Dent Child 74 (2007) 98-103
20. Starr J.R., White T.C., Leroux B.G., Luis H.S., Bernardo M., Leitao J., et al. Persistence of oral Candida albicans carriage in healthy Portuguese schoolchildren followed for 3 years. Oral Microbiol Immunol 17 (2002) 304-310
21. Kramer P.F., Feldens C.A., and Romano A.N. Diagnóstico da lesão de cárie oclusal. In: Kramer P.F., Feldens C.A., and Romano A.N. (Eds). Promoção de saúde bucal em odontopediatria-diagnóstico, prevenção e tratamento da cárie oclusal (2000), Artes Médicas, São Paulo 61-72
22. Frenken J.E. Reports in the execution of Mongoro rotation in primary oral health care in the academic year 1984-1985 (1985), University of Dar Es Salaam, Division of Dentistry, Dar Es Salaam, Tanzania
23. Berkowitz R., Obeid G., Mcllveen L., Geston P., Mohla C., and Campos J. Comparison of two sampling techniques for quantitation of oral yeast levels. Pediatr Dent 16 (1994) 62-63
24. Odds F.C., and Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32 (1994) 1923-1929
25. Lamey P.-J., Darwazeh A., Fisher B.M., Samaranayake L.P., MacFarlane T.W., and Frier B.M. Secretor status, candidal carriage and candidal infection in patients with diabetes miellitus. J Oral Pathol 17 (1988) 354-357
26. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morbid Mortal Wkly Rep 43 (1994) 1-10
27. He M., Du M., Fan M., and Bian Z. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 163 (2007) 137-143
28. Cassanho A.C.A., Fernandes A.M., Oliveira L.D., Carvalho C.A.T., Jorge A.O.C., and Koga-Ito C.Y. In vitro activity of zinc oxide-eugenol and glass ionomer cements on Candida albicans. Braz Oral Res 19 (2005) 134-138
29. Kiffer-Moreira T., de Sá Pinheiro A.A., Alviano W.S., Barbosa F.M., Souto-Padrón T., Nimrichter L., et al. An ectophosphatase activity in Candida parapsilosis influences the interaction of fungi with epithelial cells. FEMS Yeast Res 7 (2007) 621-628
30. Naglik J.R., Challacombe S.J., and Hube B. Candida albicans secreted aspartyl proteases in virulence and pathogenesis. Microbiol Mol Biol Ver 67 (2003) 400-428
31. Schaller M., Borelli C., Korting H.C., and Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48 (2005) 365-377
32. Rodier M.-H., Moudni B.E., Kauffmann-Lacroix C., Daniault G., and Jacquemin J.-L. A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix. FEMS Microbiol Lett 177 (1999) 205-210
33. Imbert C., Kauffmann-Lacroix C., Daniault G., Jacquemin J.-L., and Rodier M.H. Effect of matrix metalloprotease inhibitors on the 95 kDa metallopeptidase of Candida albicans. J Antimicrobiol Chem 49 (2002) 1007-1010
34. Kaminishi H., Hagihara Y., Tanaka M., and Cho T. Degradation of bovine Achilles tendon collagen by Candida albicans proteinase. J Med Vet Mycol 26 (1988) 315-318
35. Berkovitz B.K.B., Holland G.R., and Moxhan B.J. Dentina. In: Berkovitz B.K.B., Holland G.R., and Moxhan B.J. (Eds). Anatomia, embriologia e histologia bucal (2004), Artmed, Porto Alegre 125-148
36. Piesco N.P. Histologia da dentina. In: Avery J.K. (Ed). Desenvolvimento e histologia bucal (2005), Artmed/Editora Santos, Porto Alegre/São Paulo 188-205
37. Manfredi M., McCullough M.J., Al-Karaawi Z.M., Vescovi P., and Porter S.R. In vitro evaluation of virulence attributes of Candida spp., isolated from patients affected by diabetes mellitus. Oral Microbiol Immunol 211 (2006) 183-189
38. Mardegan R.C., Foglio M.A., Gonçalves R.B., and Höfling J.F. Candida albicans proteinases. Braz J Oral Sci 5 (2006) 944-952
39. de Brito Costa E.M., dos Santos A.L., Cardoso A.S., Portela M.B., Abreu C.M., Alviano C.S., et al. Heterogeneity of metallo and serine extracellular proteinases in oral clinical isolates of Candida albicans in HIV-positive and healthy children from Rio de Janeiro. FEMS Immunol Med Microbiol 38 (2003) 173-180
40. Ollert M.W., Wende C., Görlich M., McMullan-Vogel C.G.B.-v.Z.M., Vogel C.W., et al. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 33 (1995) 2543-2549
41. Sedgley C.M., Samaranayake L.P., Chan J.C.Y., and Wei S.H.Y. A 4-year longitudinal study of the oral prevalence of enteric gram-negative rods and yeasts in Chinese children. Oral Microbiol Immunol 12 (1997) 183-188
42. Costa C.R., Cohen A.J., and Fernandes O.F.L. Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era. Rev Inst Med Trop 48 (2006) 257-261